Bloemen, Sophie

Insufficient innovation and a lack of access to affordable medicines are major barriers to achieving the right to health in low- and middle-income countries. This paper argues that European Union trade policies should not be used to bolster pharmaceutical companies’ profits by extending their monopolies on medicine prices to supposedly reward research. Instead, the incoming […]

Access to medicines poses a critical challenge in developing countries, largely because prices are high, and new or adapted medicines and vaccine to address diseases of the developing world are lacking. ore than 5 million people in low and middle income countries still lack access to the anti-retroviral medicines needed to treat HIV and AIDS. […]